MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

GSK

  • Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market
    Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market
    GSK plans to sell generic versions of the inhalers, but many are still worried about insurance coverage for alternatives.
    December 29, 2023BY Naveen Athrappully
  • FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    A committee of outside advisers to the U.S. Food and Drug Administration (FDA) recommended a vaccine from GlaxoSmithKline (GSK) ...
    March 2, 2023BY Mimi Nguyen Ly
  • GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback
    GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback
    Britain's GSK said on Friday it would limit the use of its ovarian cancer drug Zejula in the ...
    November 11, 2022BY Reuters
  • GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was ...
    November 7, 2022BY Reuters
  • GSK Says FDA Approves Kidney Disease Drug for Children
    GSK Says FDA Approves Kidney Disease Drug for Children
    GSK Plc. said on Wednesday the Food and Drug Administration (FDA) had cleared its kidney disease drug Benlysta ...
    July 29, 2022BY Reuters
  • Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off
    Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off
    LONDON—Pfizer plans to exit its 32 percent stake in Haleon, a consumer health joint venture with British drugmaker ...
    June 1, 2022BY Reuters
  • GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines ...
    February 3, 2022BY Reuters
  • GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets
    GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets
    GlaxoSmithKline on Saturday said it had rejected a 50-billion-pound offer from Unilever for its consumer goods arm, saying ...
    January 18, 2022BY Reuters
  • Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
    Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
    The head of a medical supplies company involved in the distribution and supply of monoclonal antibodies across southeastern ...
    January 13, 2022BY Tammy Hung
  • GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
    GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
    GlaxoSmithKline PLC (GSK) said on Tuesday it would develop an HIV treatment with Japan's Shionogi for use in ...
    September 28, 2021BY Reuters
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss authorities have agreed to extradite a Chinese researcher to the United States, where he is accused of ...
    July 17, 2019BY Frank Fang
  • Drugmaker GSK to Eliminate 650 US Jobs
    Drugmaker GSK to Eliminate 650 US Jobs
    British drugmaker GlaxoSmithKline Plc said on Sept. 5 it would cut about 650 positions in the United States ...
    September 5, 2018BY Reuters
  • British Private Eye in China Prosecuted for Knowing Too Much
    British Private Eye in China Prosecuted for Knowing Too Much
    A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information ...
    July 14, 2014BY Matthew Robertson
TOP NEWS
  • Appeals Court Rejects Trump Bid to Use Immigration Database for Voter Checks
    1hr By Troy Myers
    Appeals Court Rejects Trump Bid to Use Immigration Database for Voter Checks
  • Federal Government Backs Supreme Court Challenge to AR-15 Bans
    2hr By Bill Pan
    Federal Government Backs Supreme Court Challenge to AR-15 Bans
  • NTD 8th International Piano Competition Winners Announced
    6hr By NTD Newsroom
    NTD 8th International Piano Competition Winners Announced
  • New PFAS Pesticides Are Entering Our Food System, Revealing a Conundrum
    6hr By Marina Zhang
    New PFAS Pesticides Are Entering Our Food System, Revealing a Conundrum
  • Kremlin Says Peace Talks Useful as US Envoys Leave Moscow for Kyiv
    7hr By Jacki Thrapp
    Kremlin Says Peace Talks Useful as US Envoys Leave Moscow for Kyiv
  • Labor Day Gas Prices Head for Record High
    8hr By Bill Pan
    Labor Day Gas Prices Head for Record High
  • Here’s What People Get Wrong About Modern Warfare | John Spencer
    12hr By Jan Jekielek, Epoch TV
    Here’s What People Get Wrong About Modern Warfare | John Spencer
  • State Department Says 75 Americans Remain Missing After Nepal-Tibet Flood
    12hr By Dorothy Li
    State Department Says 75 Americans Remain Missing After Nepal-Tibet Flood
  • US Forces Destroy 3 IRGC Oil Tankers After Iran Targets Navy Warships
    13hr By Jacki Thrapp
    US Forces Destroy 3 IRGC Oil Tankers After Iran Targets Navy Warships
  • Court Rules Pentagon Can Proceed With Firing Journalists
    14hr By Naveen Athrappully
    Court Rules Pentagon Can Proceed With Firing Journalists
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top